Description
Contents
Cefuroxime
Indications/Uses
ZINNAT is an oral prodrug of the bactericidal cephalosporin antibiotic cefuroxime, which is resistant to most Ξ² (beta)-lactamases and is active against a wide range of Gram-positive and Gram-negative organisms.
It is indicated for the treatment of infections caused by susceptible bacteria.
Dosage/Direction for Use
Adults:Β Tablet:Β Most infections: 250 mg twice daily.
Urinary tract infections: 250 mg twice daily.
Mild to moderate lower respiratory tract infections e.g. bronchitis: 250 mg twice daily.
More severe lower respiratory tract infections, or if pneumonia is suspected: 500 mg twice daily.
Pyelonephritis: 250 mg twice daily.
*The product images shown are for illustration purposes only and may not be an exact representation of the product.
